Oppenheimer upgraded shares of Nevro (NYSE:NVRO – Get Rating) from a market perform rating to an outperform rating in a research note published on Monday morning, The Fly reports. They currently have $40.00 price objective on the medical equipment provider’s stock. Several other brokerages have also commented on NVRO. Piper Sandler dropped their price target […]
Equities research analysts at StockNews.com began coverage on shares of Nevro (NYSE:NVRO – Get Rating) in a note issued to investors on Thursday. The firm set a “hold” rating on the medical equipment provider’s stock. A number of other research firms also recently weighed in on NVRO. Piper Sandler dropped their target price on Nevro […]
Nevro (NYSE:NVRO – Get Rating) had its price target reduced by analysts at Truist Financial from $40.00 to $32.00 in a report released on Thursday, The Fly reports. Truist Financial’s price objective indicates a potential upside of 15.19% from the stock’s previous close. Other equities research analysts have also recently issued reports about the company. […]
Nevro Corp. (NYSE:NVRO – Get Rating) shares hit a new 52-week low during trading on Monday . The stock traded as low as $26.43 and last traded at $26.43, with a volume of 18906 shares traded. The stock had previously closed at $27.08. Analysts Set New Price Targets Several research analysts have recently commented on […]
Nevro Corp. (NYSE:NVRO – Get Rating) – Investment analysts at Oppenheimer raised their Q2 2023 earnings estimates for shares of Nevro in a research report issued on Thursday, April 27th. Oppenheimer analyst S. Kalia now anticipates that the medical equipment provider will post earnings per share of ($0.62) for the quarter, up from their previous […]